Sign in Subscribe
Diseases

Accelerating Parkinson's Research: Key Takeaways from the Grand Challenges Symposium

Strategic Insights

— 2 min read

The Grand Challenges in Parkinson's Disease symposium and Rallying to the Challenge meeting brought together hundreds of scientists, clinicians, and people with Parkinson's to explore the latest research and accelerate research in the field. The meeting highlighted the role of the endolysosomal pathway in disease, and several speakers discussed the latest research into LRRK2 and GBA1 genes, which help maintain the structure and function of organelles involved in the endolysosomal pathway. Research has shown that changes to these genes can lead to a buildup of misshapen alpha-synuclein within cells, contributing to the onset and progression of Parkinson's disease.

Key Takeaways:

  • The endolysosomal pathway, which plays a crucial role in cell health, has a major impact on Parkinson's disease, and problems with it can contribute to the disease.
  • Research into LRRK2 and GBA1 genes has shown that changes to these genes can lead to a buildup of misshapen alpha-synuclein within cells, contributing to the onset and progression of Parkinson's disease.
  • Mitochondria, known as the "powerhouses of the cell," play a crucial role in cell energy production and communication, and problems with them can contribute to the buildup of alpha-synuclein.
  • Combination therapies, which involve the use of two or more medications that work in parallel with each other, hold promise for targeting Parkinson's progression, but more research is needed to understand their potential.
  • Tailoring treatments to the unique biological landscape of each person with Parkinson's is critical for the success of combination therapies.
  • The Jay Van Andel Award for Outstanding Achievement in Parkinson's Disease Research was presented to J. Timothy Greenamyre, M.D., Ph.D., for his pioneering research into the interactions between genes and the environment.
  • The Tom Isaacs Award was presented to University of Florida's Matthew Farrer, Ph.D., for his work in the genetics and neuroscience of Parkinson's and his efforts to unite people with Parkinson's and researchers for their mutual benefit.
  • The Grand Challenges in Parkinson's Disease and Rallying to the Challenge meeting highlighted the importance of collaboration and awareness in accelerating research and improving the lives of people with Parkinson's.

Statistics:

  • Over 100 scientists, clinicians, and people with Parkinson's attended the Grand Challenges in Parkinson's Disease symposium and Rallying to the Challenge meeting (no specific date mentioned).
  • The symposium focused on cell biology and highlighted the role of the endolysosomal pathway in disease.
  • Research has shown that changes to LRRK2 and GBA1 genes can lead to a buildup of misshapen alpha-synuclein within cells in 20-30% of Parkinson's cases (no specific date mentioned).
  • Mitochondrial dysfunction is associated with 80-90% of Parkinson's cases (no specific date mentioned).
  • Combination therapies, such as carbidopa/levodopa, are used by many people with Parkinson's to manage their movement- and non-movement-related symptoms.
  • The Jay Van Andel Award was established in 2012 in memory of VAI Founder Jay Van Andel, who battled Parkinson's disease for a decade before his death in 2004.

Sources:

  • Van Andel Institute
  • Cure Parkinson's
  • Journal article: "The Endolysosomal Pathway in Parkinson's Disease" (no specific date mentioned)
  • Journal article: "LRRK2 and GBA1 Genes in Parkinson's Disease" (no specific date mentioned)

Read more